Nine-Year Follow-Up of Interleukin 6 in Chronic Obstructive Pulmonary Disease – Complementary Results from Previous Studies
Robson Prudente,1 Renata Ferrari,2 Carolina Mesquita,2 Luiz Machado,2 Estefânia Franco,1 Irma Godoy,2 Suzana Tanni2 1Clinical Hospital of Botucatu Medical School, Department of Internal Medicine, Pneumology Area, Botucatu School of Medicine, São Paulo State University (UNESP), Botucatu, São Paulo, B...
Enregistré dans:
Auteurs principaux: | Prudente R, Ferrari R, Mesquita C, Machado L, Franco E, Godoy I, Tanni S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d0011968a77a43b0a92278e6e8d835d3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer
par: Liao KM, et autres
Publié: (2021) -
The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea
par: Lu Yan, et autres
Publié: (2021) -
Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study
par: Chun-Mei Feng, et autres
Publié: (2021) -
Right Atrium Volume Index in Non-Severe Chronic Obstructive Pulmonary Disease
par: Cherneva Zh., et autres
Publié: (2020) -
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
par: Choi JH, et autres
Publié: (2021)